Please use this identifier to cite or link to this item: http://doi.org/10.25358/openscience-8060
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSchlöder, Janine-
dc.contributor.authorBerges, Carsten-
dc.contributor.authorLüssi, Felix-
dc.contributor.authorJonuleit, Helmut-
dc.date.accessioned2022-10-17T07:55:58Z-
dc.date.available2022-10-17T07:55:58Z-
dc.date.issued2017
dc.identifier.urihttps://openscience.ub.uni-mainz.de/handle/20.500.12030/8075-
dc.description.abstractMultiple sclerosis (MS) is a chronic autoimmune disease caused by an insufficient suppression of autoreactive t lymphocytes. one reason for the lack of immunological control is the reduced responsiveness of t effector cells (teff) for the suppressive properties of regulatory t cells (treg), a process termed treg resistance. here we investigated whether the disease-modifying therapy of relapsing-remitting ms (rrms) with dimethyl fumarate (dmf) influences the sensitivity of t cells in the peripheral blood of patients towards treg-mediated suppression. we demonstrated that dmf restores responsiveness of teff to the suppressive function of treg in vitro, presumably by down-regulation of interleukin-6r (il-6r) expression on t cells. transfer of human immune cells into immunodeficient mice resulted in a lethal graft-versus-host reaction triggered by human cd4+ teff. this systemic inflammation can be prevented by activated treg after transfer of immune cells from dmf-treated ms patients, but not after injection of treg-resistant teff from therapy-naïve ms patients. furthermore, after dmf therapy, proliferation and expansion of t cells and the immigration into the spleen of the animals is reduced and modulated by activated treg. in summary, our data reveals that dmf therapy significantly improves the responsiveness of teff in ms patients to immunoregulation.en_GB
dc.description.sponsorshipDFG, Open Access-Publizieren Universität Mainz / Universitätsmedizinde
dc.language.isoengde
dc.rightsCC BY*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subject.ddc610 Medizinde_DE
dc.subject.ddc610 Medical sciencesen_GB
dc.titleDimethyl fumarate therapy significantly improves the responsiveness of T cells in multiple sclerosis patients for immunoregulation by regulatory T cellsen_GB
dc.typeZeitschriftenaufsatzde
dc.identifier.doihttp://doi.org/10.25358/openscience-8060-
jgu.type.dinitypearticleen_GB
jgu.type.versionPublished versionde
jgu.type.resourceTextde
jgu.organisation.departmentFB 04 Medizinde
jgu.organisation.number2700-
jgu.organisation.nameJohannes Gutenberg-Universität Mainz-
jgu.rights.accessrightsopenAccess-
jgu.journal.titleInternational journal of molecular sciencesde
jgu.journal.volume18de
jgu.journal.issue2de
jgu.pages.alternativeArt. 271de
jgu.publisher.year2017-
jgu.publisher.nameMolecular Diversity Preservation Internationalde
jgu.publisher.placeBaselde
jgu.publisher.urihttp://dx.doi.org/10.3390/ijms18020271de
jgu.publisher.issn1422-0067de
jgu.publisher.issn1661-6596de
jgu.organisation.placeMainz-
jgu.subject.ddccode610de
opus.date.modified2018-03-23T11:08:09Z
opus.subject.dfgcode00-000
opus.organisation.stringFB 04: Medizin: Hautklinikde_DE
opus.organisation.stringFB 04: Medizin: Klinik und Poliklinik für Neurologiede_DE
opus.identifier.opusid57997
opus.institute.number0431
opus.institute.number0435
opus.metadataonlyfalse
opus.type.contenttypeKeinede_DE
opus.type.contenttypeNoneen_EN
opus.affiliatedSchlöder, Janine
opus.affiliatedLüssi, Felix
opus.affiliatedJonuleit, Helmut
jgu.publisher.doi10.3390/ijms18020271de
jgu.organisation.rorhttps://ror.org/023b0x485-
Appears in collections:DFG-OA-Publizieren (2012 - 2017)

Files in This Item:
  File Description SizeFormat
Thumbnail
dimethyl_fumarate_therapy_sig-20220925165506779.pdf2.72 MBAdobe PDFView/Open